Shalini Subramaniam

5PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Medical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 28, 2026
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Apr 15, 2026
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial.

|Jan 11, 2024
Patients' perception of the benefits of palliative systemic therapy for advanced cancer.

Shalini Subramaniam, Diana H Adams, Annette Tognela

|Jul 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501).

Dickon Hayne, Jeremy Grummet, David Espinoza

|May 24, 2021
ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).

Louise Emmett, Shalini Subramaniam, Anthony M Joshua

Pageof 1

Frequent Collaborators

3 joint publications

Louise Emmett

2 joint publications

Michael S Hofman

2 joint publications

Martin R Stockler

2 joint publications

Shahneen Sandhu